Global Blood Transfusion Diagnostics Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

By Product Type;

Instruments and Kits & Reagents.

By Application;

Blood Grouping and Disease Screening - Serological Disease Screening and Molecular Disease Screening.

By End USers;

Hospitals, Blood Banks, Diagnostic Laboratories, Plasma Fractionation Companies and Others.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2020 - 2030).
Report ID: Rn874441362 Published Date: June, 2024 Updated Date: July, 2024


Global Blood Transfusion Diagnostics Market (USD Million), 2020 - 2030

In the year 2023, the Global Blood Transfusion Diagnostics Market was valued at USD 5,666.69 million. The size of this market is expected to increase to USD 8,708.03 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 6.3%.

The global blood transfusion diagnostics market plays a pivotal role in ensuring the safety and efficacy of blood transfusion procedures worldwide. Blood transfusion diagnostics involve a series of tests and screening procedures conducted to ensure the compatibility of donated blood with the recipient's blood type, as well as to detect any potential infectious agents or antibodies that may pose risks to the recipient's health. These diagnostics are essential in preventing transfusion-transmitted infections and adverse reactions, thereby safeguarding patient health during transfusion procedures.

The increasing demand for blood transfusions, driven by rising surgical procedures, trauma cases, and the prevalence of chronic diseases, underscores the importance of robust blood transfusion diagnostics. With advancements in medical technology and healthcare infrastructure, the global blood transfusion diagnostics market has witnessed significant growth in recent years. Moreover, stringent regulatory standards and guidelines governing blood safety and transfusion practices have further propelled market growth, necessitating the adoption of advanced diagnostic solutions to ensure compliance and patient safety.

Blood transfusion diagnostics encompass a range of tests, including ABO and Rh typing, compatibility testing, screening for infectious diseases such as HIV, hepatitis, and syphilis, as well as antibody screening. These tests are conducted at various stages of the transfusion process, from donor screening and blood collection to recipient testing and post-transfusion monitoring. As the demand for safe and reliable blood transfusions continues to rise globally, the blood transfusion diagnostics market is expected to witness sustained growth, driven by ongoing technological advancements, increasing healthcare expenditure, and growing awareness of blood safety practices among healthcare providers and patients alike.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product Type
    2. Market Snapshot, By Application
    3. Market Snapshot, By End USers
    4. Market Snapshot, By Region
  4. Global Blood Transfusion Diagnostics Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing Demand for Blood Transfusions
        2. Stringent Regulatory Standards
        3. Growing Awareness of Blood Safety
        4. Advancements in Medical Technology
        5. Rising Healthcare Expenditure
      2. Restraints
        1. Stringent Regulatory Requirements
        2. Limited Access to Advanced Technologies
        3. High Cost of Diagnostic Tests
        4. Concerns Regarding Blood Safety
        5. Blood Supply Shortages
      3. Opportunities
        1. Adoption of Point-of-Care Testing
        2. Expansion of Donor Screening Programs
        3. Emphasis on Molecular Diagnostics
        4. Development of Advanced Serological Assays
        5. Integration of Automation and Robotics
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Blood Transfusion Diagnostics Market , By Product Type, 2020 - 2030 (USD Million)
      1. Instruments
      2. Kits & Reagents
    2. Global Blood Transfusion Diagnostics Market , By Application, 2020 - 2030 (USD Million)
      1. Blood Grouping
      2. Disease Screening
        1. Serological Disease Screening
        2. Molecular Disease Screening
    3. Global Blood Transfusion Diagnostics Market , By End USers, 2020 - 2030 (USD Million)
      1. Hospitals
      2. Blood Banks
      3. Diagnostic Laboratories
      4. Plasma Fractionation Companies
      5. Others
    4. Global Blood Transfusion Diagnostics Market , By Geography, 2020 - 2030 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Ortho Clinical Diagnostics
      2. Grifols, S.A
      3. F. Hoffmann-La Roche Ltd
      4. Immucor, Inc
      5. Bio-Rad Laboratories, Inc
      6. Abbott Laboratories
      7. Danaher Corporation
      8. Siemens Healthineers AG
      9. Becton, Dickinson and Company (BD)
      10. Thermo Fisher Scientific Inc
  7. Analyst Views
  8. Future Outlook of the Market